A phase I study of HYB2055 in patients (pts) with advanced solid malignancies

被引：0
|
作者：
Hwang, JJ
Park, S
Amin, A
Martin, RR
Sullivan, T
Burns, T
Agrawal, S
Waxdal, MJ
Malik, S
Marshall, JL
机构：
[1] Georgetown Univ, Med Ctr, Washington, DC 20057 USA
[2] Hybridon Inc, Cambridge, MA USA
[3] Fast Syst, Gaithersburg, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3111
引用
收藏
页码：222S / 222S
页数：1
相关论文
共 50 条
  • [41] A Phase I study of indoximod in patients with advanced malignancies
    Soliman, Hatem H.
    Minton, Susan E.
    Han, Hyo Sook
    Ismail-Khan, Roohi
    Neuger, Anthony
    Khambati, Fatema
    Noyes, David
    Lush, Richard
    Chiappori, Alberto A.
    Roberts, John D.
    Link, Charles
    Vahanian, Nicholas N.
    Mautino, Mario
    Streicher, Howard
    Sullivan, Daniel M.
    Antonia, Scott J.
    ONCOTARGET, 2016, 7 (16) : 22928 - 22938
  • [42] Phase I trial of SNS-595 in patients (pts) with advanced malignancies.
    Advani, R
    Gordon, M
    Hurwitz, H
    Mendelson, D
    Wakelee, H
    Ebbinghaus, S
    Hoch, U
    Silverman, J
    Havrilla, N
    Adelman, D
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9056S - 9056S
  • [43] Phase I study of ATN-224 in patients (pts) with advanced solid tumours.
    Lowndes, S. A.
    Adams, A.
    Timms, A.
    Middleton, M.
    Hayward, C.
    Reich, S. D.
    Mazar, A. P.
    Harris, A. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 95S - 95S
  • [44] A phase I study of flavopiridol using an alternative schedule in patients (pts) with advanced solid tumors
    Ramaswamy, B.
    Phelps, M.
    Baiocchi, R.
    Bekaii-Saab, T.
    Wilkins, D.
    Arbogast, D.
    Campbell, A.
    Doyle, A. L.
    Grever, M.
    Shah, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Phase I study of WNT974+spartalizumab in patients (pts) with advanced solid tumors
    Janku, Filip
    de Vos, Filip
    de Miguel, Maria
    Forde, Patrick
    Ribas, Antoni
    Nagasaka, Misako
    Argiles, Guillem
    Arance, Ana Maria
    Calvo, Aitano
    Giannakis, Marios
    Melendez, Maritza
    Gong, Jiachang
    Szpakowski, Sebastian
    Kan, Rebecca
    Moody, Susan E.
    De Jonge, Maja
    CANCER RESEARCH, 2020, 80 (16)
  • [46] A phase 1 placebo-controlled study in volunteers of escalating doses of HYB2055, a second-generation immunomodulatory agent based on CpG DNA.
    Martin, R
    Sullivan, T
    Bhagat, L
    Kandimalla, E
    Wang, D
    Zhao, Q
    Burton, C
    Bryson, P
    Ng, T
    Binney, S
    Handy, L
    Agrawal, S
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6227S - 6227S
  • [47] A phase I study to evaluate safety, tolerability, pharmacokinetics and activity of oraxol in patients (pts) with advanced malignancies.
    Ma, Wen Wee
    Azad, Nilofer Saba
    Lam, Elaine Tat
    Diamond, Jennifer Robinson
    Dy, Grace K.
    Opyrchal, Mateusz
    Gallagher, Denise
    Brennen, Caden
    Cutler, David
    Kramer, Douglas
    Chan, Wing Kai
    Kwan, Rudolf
    Fetterly, Gerald J.
    Adjei, Alex A.
    Jimeno, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Phase I/II study of MAK683 in patients (pts) with advanced malignancies including epithelioid sarcoma
    Bahleda, R.
    Wainberg, Z. A.
    Spreafico, A.
    Ma, B.
    Subbiah, V.
    Ribrag, V.
    Duca, M.
    Fan, Y. Y.
    Cheng, Y.
    Lai, C.
    De Braud, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S1113 - S1114
  • [49] Phase I Study of Fixed Dose Gemcitabine Plus Epirubicin in Patients With Advanced Solid Malignancies
    Mahadevan, Daruka
    Dreisbach, Luke
    Kristedja, Timothy
    Williams, Debbie
    Obregon, Yrma
    Kurtin, Sandy
    Von Hoff, Daniel D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (06): : 607 - 611
  • [50] A phase I clinical and pharmacokinetic study of ipifarnib in combination with docetaxel in patients with advanced solid malignancies
    Awada, Ahmad
    Zhang, Steven
    Gil, Thierry
    de Valeriola, Dominique
    Lalami, Yassine
    De Porre, Peter
    Piccart-Gebhart, Martine J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 991 - 1003
12345